VF
OGEN icon

Virtu Financial’s Oragenics OGEN Stock Holding History

Virtu Financial’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10K Buy
+17,575
New +$13.9K ﹤0.01% 1462
2024
Q4 		– Sell
-696
Closed -$8K – 1903
2024
Q3 		$8K Buy
696
+290
+71% +$8.19K ﹤0.01% 1222
2024
Q2 		$13K Sell
406
-350
-46% -$15.8K ﹤0.01% 1099
2024
Q1 		$33K Buy
+756
New +$74.6K ﹤0.01% 1089
2022
Q4 		– Sell
-17
Closed -$7K – 1990
2022
Q3 		$7K Buy
17
+3
+21% +$1.75K ﹤0.01% 1555
2022
Q2 		$9K Sell
14
-8
-36% -$4.62K ﹤0.01% 1430
2022
Q1 		$14K Sell
22
-83
-79% -$60.9K ﹤0.01% 1342
2021
Q4 		$84K Sell
105
-39
-27% -$39.5K 0.01% 1201
2021
Q3 		$165K Buy
144
+108
+300% +$130K 0.01% 973
2021
Q2 		$46K Buy
36
+24
+200% +$31.6K ﹤0.01% 1346
2021
Q1 		$19K Sell
12
-79
-87% -$143K ﹤0.01% 1512
2020
Q4 		$74K Sell
91
-58
-39% -$51K 0.01% 1139
2020
Q3 		$154K Buy
+149
New +$238K 0.03% 644
2019
Q4 		$52K Buy
55
+35
+175% +$31.2K 0.01% 1195
2019
Q3 		$19K Sell
20
-22
-52% -$18.4K ﹤0.01% 1296
2019
Q2 		$37K Buy
42
+35
+500% +$32.1K ﹤0.01% 1283
2019
Q1 		$8K Sell
7
-70
-91% -$110K ﹤0.01% 1347
2018
Q4 		$119K Buy
77
+58
+305% +$114K 0.01% 1093
2018
Q3 		$40K Sell
19
-14
-42% -$16.1K ﹤0.01% 1329
2018
Q2 		$83K Buy
33
+27
+450% +$71K 0.01% 1683
2018
Q1 		$19K Buy
6
+3
+100% +$11.1K ﹤0.01% 1818
2017
Q4 		$13K Buy
3
+2
+200% +$12.6K ﹤0.01% 2252
2017
Q3 		$6K Buy
+1
New +$6.61K ﹤0.01% 2427

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Virtu Financial's OGEN Position: Q1 2026 in Review

Virtu Financial opened a new position in Oragenics (OGEN) in Q1 2026: 17,575 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #1462 among its holdings. This is a return to the name: Virtu Financial previously reported a position in OGEN as recently as Q3 2024.

Virtu Financial first reported a position in OGEN in Q3 2017 and has held it in 23 quarters since. The position peaked at $165K in Q3 2021. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • Virtu Financial held 17,575 shares of Oragenics worth $10K as of Q1 2026.
  • Oragenics was a new Virtu Financial position in Q1 2026.
  • Oragenics made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1462 holding.
  • Virtu Financial first reported a position in Oragenics in Q3 2017 and has held it in 23 quarters since.
  • Virtu Financial's Oragenics position peaked at $165K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.